XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Appreciation Rights (Tables)
3 Months Ended
Jul. 31, 2012
SARS [Abstract]  
Stock Appreciation Rights Vesting Schedule [Table Text Block]
Number of Years the Grantee has remained
a Torotel director following the Date of Grant
Shares represented
by a SAR in which
a Grantee is Vested
Under one
%
At least one but less than two
33
%
At least two but less than three
67
%
Three or more
100
%
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block]
 
2012
2011
 
SARs
Under
Option
Weighted
Average
Grant
Price
SARs
Under
Option
Weighted
Average
Grant
Price
Outstanding at beginning of period
280,000

$
0.429

240,000

$
0.407

Granted
40,000

$
0.270

40,000

$
0.560

Exercised

$


$

Forfeited

$


$

Outstanding at end of period
320,000

$
0.409

280,000

$
0.428

SARs exercisable at end of period
243,300

$
0.418

210,000

$
0.428

Weighted average fair value of SARs granted during the period
 

$
0.270

 

$
0.560

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
2012
2011
Number outstanding
320,000

280,000

Range of grant prices, upper limit
$
0.695

$
0.695

Range of grant prices, lower limit
$
0.208

$
0.208

Weighted average grant price
$
0.418

$
0.428

Weighted average contractual life remaining (in years)
5.61

6.04

10-day average market price
$
0.270

$
0.560

Weighted average stock volatility
143.73
%
134.74
%
Weighted average expected life
4.84

3.00

Weighted average risk free rate
0.69
%
1.54
%
Weighted average dividend yield
%
%
Weighted average fair value price
$
0.389

$
0.444

Total vested SARs
243,300

210,000

Aggregate fair value
$
57,000

$
69,000

Aggregate intrinsic value
$
2,400

$
42,000

Total compensation expense (benefit)
$
6,800

$
(11,000
)
Unrecognized compensation expense related to non-vested SARs granted
$
18,000

$
23,000

Expected period to recognize compensation expense related to non-vested SARs granted (in years)
2.28

2.23

Total liability for SARs on consolidated balance sheets
$
59,000

$
69,000